CHERYL VICKERS: Open Payments
NPI 1891214383 · RUSSELLVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$455 in 23 payments from 11 companies in 2025. Trend: 2023 $165 · 2024 $417 · 2025 $455
Food & beverage: $455
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $111 |
| Axsome Therapeutics, Inc. | 4 | $74 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $65 |
| Alkermes, Inc. | 2 | $33 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Lundbeck LLC | 1 | $27 |
| Dexcom, Inc. | 1 | $27 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
Products named: XIFAXAN, Auvelity, CAPLYTA, REXULTI, VOQUEZNA, FANAPT, Dexcom G6 Transmitter, Jornay PM.
Industry payments across KY — which companies pay providers there.
